BFLY vs TMDX
Butterfly Network, Inc. vs TransMedics Group, Inc. — AI-powered side-by-side comparison
BFLY
Butterfly Network, Inc.
67
Buy
VS
TMDX
TransMedics Group, Inc.
60
Buy
| Metric | BFLY | TMDX |
| AI Score |
67
|
60
|
| Price |
$9.36
|
$89.39
|
| P/E Ratio |
-32.38×
|
20.22×
|
| ROE |
-39.3%
|
40.2%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
51.1%
|
58.7%
|
| Debt / Equity |
0.10×
|
1.68×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
66.4
|
76.9
|
| Beta |
2.084
|
1.88
|
| Expected Upside |
—
|
—
|
AI Committee View
Current Innellis committee reasoning for BFLY versus TMDX.
BFLY leads by 7 points.
BFLY scores 67/100 (Buy) versus TMDX at 60/100 (Buy).
BFLY Committee View
67% agreement
6 analysts
The primary driver is revenue growing 28.1% yoy -- genuine top-line momentum. The main limiting factor is roe of only -38.4% -- cheap may mean cheap for a reason. The committee is constructive but not yet at full conviction.
Bull Case
- Revenue growing 28.1% YoY -- genuine top-line momentum — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- ROE of only -38.4% -- cheap may mean cheap for a reason — Value
- Bollinger bandwidth of 52.6% signals elevated volatility — Risk
TMDX Committee View
50% agreement
6 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 25.8% yoy -- genuine top-line momentum. Risk Analyst remains cautious — bollinger bandwidth of 26.6% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- ROE of 33.0% shows genuine earnings power backing the valuation — Value
- Revenue growing 25.8% YoY -- genuine top-line momentum — Growth
- EPS growing 105.5% YoY — Growth
Bear Case
- Price-to-book of 8.8x prices in significant intangible value — Value
- RSI at 77 is in overbought territory — Technical
- Price trading above the upper Bollinger Band -- stretched — Technical